Chai Discovery vs Grok

Side-by-side comparison of AI visibility scores, market position, and capabilities

Chai Discovery leads in AI visibility (69 vs 49)
Chai Discovery logo

Chai Discovery

ChallengerHealthcare Tech

AI Molecular Discovery

AI molecular discovery unicorn ($1.3B valuation). 100x improvement in de novo antibody design success. Backed by OpenAI. Eli Lilly partnership. Founded 2023, SF. $225M+ raised.

AI VisibilityBeta
Overall Score
B69
Category Rank
#1 of 1
AI Consensus
77%
Trend
up
Per Platform
ChatGPT
74
Perplexity
74
Gemini
73

About

Chai Discovery is an AI-driven molecular discovery company founded in 2024 and headquartered in San Francisco. The company was spun out of research conducted by scientists with backgrounds at leading computational biology and AI organizations, with the founding mission of applying the latest advances in generative AI to accelerate drug discovery — particularly the historically difficult challenge of designing novel antibodies and small molecules from scratch rather than optimizing known chemical scaffolds.\n\nChai's core technology is a foundation model for molecular structure prediction and de novo design that operates across proteins, small molecules, nucleic acids, and their complexes. The company's flagship research achievement is a reported 100-fold improvement in de novo antibody design success rates, enabling the generation of functional antibody candidates without requiring extensive experimental screening campaigns. Chai Discovery has established a research partnership with Eli Lilly, one of the world's largest pharmaceutical companies, to apply its platform to therapeutic target programs. The company is backed by OpenAI, reflecting the deep connection between large-scale AI modeling techniques and the biological sequence-structure-function prediction task.\n\nChai Discovery reached a $1.3 billion valuation within its first year of operation, an exceptionally rapid ascent reflecting the strategic premium investors place on AI-native molecular discovery platforms. The company operates at the intersection of structural biology, generative AI, and therapeutic development, competing with platforms like Isomorphic Labs, Recursion, and Insilico Medicine in the race to demonstrate AI-designed drugs in human clinical trials.

Full profile
Grok logo

Grok

ChallengerAI & Machine Learning

AI Assistant

AI assistant by xAI (Elon Musk); Grok 3 topped reasoning benchmarks in Feb 2025; 1M+ paying subscribers in week one; real-time X post access; distributed via X Premium; xAI valued at $24B.

AI VisibilityBeta
Overall Score
C49
Category Rank
#4 of 4
AI Consensus
59%
Trend
up
Per Platform
ChatGPT
43
Perplexity
49
Gemini
51

About

Grok is the AI assistant developed by xAI, Elon Musk's AI company founded in 2023, and distributed primarily through X (formerly Twitter). Grok launched in November 2023 as an X Premium perk, with the notable differentiator of real-time access to X posts and a less restricted, more direct conversational style. Grok 3, released in February 2025, achieved top scores on the AIME math reasoning benchmark and ARC-AGI test, briefly positioning xAI as a frontier model lab.

Full profile

AI Visibility Head-to-Head

69
Overall Score
49
#1
Category Rank
#4
77
AI Consensus
59
up
Trend
up
74
ChatGPT
43
74
Perplexity
49
73
Gemini
51
65
Claude
42
70
Grok
59

Key Details

Category
AI Molecular Discovery
AI Assistant
Tier
Challenger
Challenger
Entity Type
brand
product

Capabilities & Ecosystem

Capabilities

Only Chai Discovery
AI Molecular Discovery
Only Grok
AI Assistant
Grok is classified as product (part of xAI).

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.